Genetically engineered nanocarriers for drug delivery

International Journal of Nanomedicine

Volumn 9, Issue 1, 2014, Pages 1617-1626

  Shi, Pu ^a   Gustafson, Joshua A ^a   Andrew MacKay, J ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

GE drug carriers; Gene delivery; Non polymeric drug carrier; Polymeric drug carrier

Indexed keywords

ELASTIN; ELASTIN LIKE POLYPEPTIDE; EXTENDED RECOMBINANT POLYPEPTIDE POLYMER; NANOCARRIER; NANOFIBER; NANOPARTICLE; POLYMER; POLYPEPTIDE; RAPAMYCIN; SECONDARY LYMPHOID TISSUE CHEMOKINE; SILK; SILK ELASTIN LIKE POLYPEPTIDE; SILK LIKE POLYPEPTIDE; UNCLASSIFIED DRUG; VAULT PROTEIN; VIRUS PROTEIN;

AMINO ACID SEQUENCE; BINDING AFFINITY; BREAST CANCER; CHEMICAL STRUCTURE; DIABETES MELLITUS; DISEASE MODEL; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG PROTEIN BINDING; GENE DELIVERY SYSTEM; GENETIC ENGINEERING; MOSAIC VIRUS; NANOTECHNOLOGY; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN QUATERNARY STRUCTURE; PROTEIN TERTIARY STRUCTURE; REVIEW; SJOEGREN SYNDROME; TUMOR XENOGRAFT;

GE DRUG CARRIERS; GENE DELIVERY; NON-POLYMERIC DRUG CARRIER; POLYMERIC DRUG CARRIER;

ANIMALS; GENE TRANSFER TECHNIQUES; GENETIC ENGINEERING; GENETIC THERAPY; HUMANS; MOLECULAR TARGETED THERAPY; NANOCAPSULES; RECOMBINANT PROTEINS;

EID: 84897103762     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S53886     Document Type: Review

References (59)

1. Langer R. Drug delivery and targeting. Nature. 1998;392(Suppl 6679):5-10.
2. Rabotyagova OS, Cebe P, Kaplan DL. Protein-based block copolymers. Biomacromolecules. 2011;12(2):269-289.
3. Hecht S. Construction with macromolecules. Mater Today. 2005;8(3): 48-55.
4. Janib SM, Pastuszka MF, Aluri S, et al. A quantitative recipe for engineering protein polymer nanoparticles. Polym Chem. 2014;5(5):1614-1625.
5. MacKay J, Chen M, McDaniel JR, Liu W, Simnick AJ, Chilkoti A. Self-assembling chimeric polypeptide-doxorubicin conjugate nanoparticles that abolish tumours after a single injection. Nat Mater. 2009;8(12): 993-999.
6. Sun G, Hsueh PY, Janib SM, Hamm-Alvarez S, Andrew MacKay J. Design and cellular internalization of genetically engineered polypeptide nanoparticles displaying adenovirus knob domain. J Control Release. 2011;155(2):218-226.
7. Buehler DC, Toso DB, Kickhoefer VA, Zhou ZH, Rome LH. Vaults engineered for hydrophobic drug delivery. Small. 2011;7(10):1432-1439.
8. Koehl P, Delarue M. Polar and nonpolar atomic environments in the protein core: implications for folding and binding. Proteins. 1994;20(3): 264-278.
9. Elemans JAAW, Rowan AE, Nolte RJM. Mastering molecular matter. Supramolecular architectures by hierarchical self-assembly. J Mater Chem. 2003;13(11):2661-2670.
10. Urry DW. Physical chemistry of biological free energy transduction as demonstrated by elastic protein-based polymers. J Phys Chem B. 1997;101(51):11007-11028.
11. Valluzzi R, Winkler S, Wilson D, Kaplan DL. Silk: molecular organization and control of assembly. Philos Trans R Soc Lond B Biol Sci. 2002;357(1418):165-167.
12. Schellenberger V, Wang CW, Geething NC, et al. A recombinant polypeptide extends the in vivo half-life of peptides and proteins in a tunable manner. Nat Biotechnol. 2009;27(12):1186-1190.
13. Megeed Z, Cappello J, Ghandehari H. Genetically engineered silk-elastinlike protein polymers for controlled drug delivery. Adv Drug Deliv Rev. 2002;54(8):1075-1091.
14. Georgens C, Weyermann J, Zimmer A. Recombinant virus like particles as drug delivery system. Curr Pharm Biotechnol. 2005;6(1):49-55.
15. Frandsen JL, Ghandehari H. Recombinant protein-based polymers for advanced drug delivery. Chem Soc Rev. 2012;41(7):2696-2706.
16. Urry DW, Urry KD, Szaflarski W, Nowicki M. Elastic-contractile model proteins: physical chemistry, protein function and drug design and delivery. Adv Drug Deliv Rev. 2010;62(15):1404-1455.
17. Cappello J, Crissman J, Dorman M, et al. Genetic engineering of structural protein polymers. Biotechnol Prog. 1990;6(3):198-202.
18. Shah M, Hsueh PY, Sun G, Chang HY, Janib SM, Mackay JA. Biodegradation of elastin-like polypeptide nanoparticles. Protein Sci. 2012;21(6):743-750.
19. Gustafson JA, Price RA, Greish K, Cappello J, Ghandehari H. Silk-elastin-like hydrogel improves the safety of adenovirus-mediated gene-directed enzyme-prodrug therapy. Mol Pharm. 2010;7(4):1050-1056.
20. Ferrari FA, Richardson C, Chambers J, et al, inventors; Protein Polymer Technologies Inc., assignee. Construction of synthetic DNA and its use in large polypeptide synthesis. United States patent US 5243038. September 7, 1993.
21. Aluri S, Pastuszka MK, Moses AS, MacKay JA. Elastin-like peptide amphiphiles form nanofibers with tunable length. Biomacromolecules. 2012;13(9):2645-2654.
22. Pastuszka MK, Janib SM, Weitzhandler I, Okamoto CT, Hamm-Alvarez S, MacKay JA. A tunable and reversible platform for the intracellular formation of genetically engineered protein microdomains. Biomacromolecules. 2012;13(11):3439-3444.
23. Janib SM, Liu S, Park R, et al. Kinetic quantification of protein polymer nanoparticles using non-invasive imaging. Integr Biol (Camb). 2013;5(1):183-194.
24. Ravi S, Krishnamurthy VR, Caves JM, Haller CA, Chaikof EL. Maleimide-thiol coupling of a bioactive peptide to an elastin-like protein polymer. Acta Biomater. 2012;8(2):627-635.
25. Elia R, Newhide DR, Pedevillano PD, et al. Silk-hyaluronan-based composite hydrogels: a novel, securable vehicle for drug delivery. J Biomater Appl. 2013;27(6):749-762.
26. Numata K, Mieszawska-Czajkowska AJ, Kvenvold LA, Kaplan DL. Silk-based nanocomplexes with tumor-homing peptides for tumor-specific gene delivery. Macromol Biosci. 2012;12(1):75-82.
27. Numata K, Reagan MR, Goldstein RH, Rosenblatt M, Kaplan DL. Spider silk-based gene carriers for tumor cell-specific delivery. Bioconjug Chem. 2011;22(8):1605-1610.
28. Xia XX, Xu Q, Hu X, Qin G, Kaplan DL. Tunable self-assembly of genetically engineered silk-elastin-like protein polymers. Biomacromolecules. 2011;12(11):3844-3850.
29. Kim W, Xiao J, Chaikof EL. Recombinant amphiphilic protein micelles for drug delivery. Langmuir. 2011;27(23):14329-14334.
30. Amiram M, Quiroz FG, Callahan DJ, Chilkoti A. A highly parallel method for synthesizing DNA repeats enables the discovery of 'smart' protein polymers. Nat Mater. 2011;10(2):141-148.
31. Simnick AJ, Amiram M, Liu W, et al. In vivo tumor targeting by a NGR-decorated micelle of a recombinant diblock copolypeptide. J Control Release. 2011;155(2):144-151.
32. Fluegel S, Buehler J, Fischer K, McDaniel JR, Chilkoti A, Schmidt M. Self-assembly of monodisperse oligonucleotide-elastin block copolymers into stars and compound micelles. Chemistry. 2011;17(20): 5503-5506.
33. Dreher MR, Simnick AJ, Fischer K, et al. Temperature triggered self-assembly of polypeptides into multivalent spherical micelles. J Am Chem Soc. 2008;130(2):687-694.
34. García-Arévalo C, Bermejo-Martín JF, Rico L, et al. Immunomodulatory nanoparticles from elastin-like recombinamers: single-molecules for tuberculosis vaccine development. Mol Pharm. 2013;10(2):586-597.
35. Lewis RV. Spider silk: ancient ideas for new biomaterials. Chem Rev. 2006;106(9):3762-3774.
36. Pritchard EM, Kaplan DL. Silk fibroin biomaterials for controlled release drug delivery. Expert Opin Drug Deliv. 2011;8(6):797-811.
37. Numata K, Kaplan DL. Silk-based delivery systems of bioactive molecules. Adv Drug Deliv Rev. 2010;62(15):1497-1508.
38. Cappello J, Crissman JW, Crissman M, et al. In-situ self-assembling protein polymer gel systems for administration, delivery, and release of drugs. J Control Release. 1998;53(1-3):105-117.
39. Price R, Gustafson J, Greish K, Cappello J, McGill L, Ghandehari H. Comparison of silk-elastinlike protein polymer hydrogel and poloxamer in matrix-mediated gene delivery. Int J Pharm. 2012;427(1):97-104.
40. Farmer RS, Kiick KL. Conformational behavior of chemically reactive alanine-rich repetitive protein polymers. Biomacromolecules. 2005;6(3):1531-1539.
41. Dhandhukia J, Weitzhandler I, Wang W, MacKay JA. Switchable elastin-like polypeptides that respond to chemical inducers of dimerization. Biomacromolecules. 2013;14(4):976-985.
42. Shi P, Aluri S, Lin YA, et al. Elastin-based protein polymer nanoparticles carrying drug at both corona and core suppress tumor growth in vivo. J Control Release. 2013;171(3):330-338.
43. Shah M, Edman MC, Janga SR, et al. A rapamycin-binding protein polymer nanoparticle shows potent therapeutic activity in suppressing autoimmune dacryoadenitis in a mouse model of Sjogren's syndrome. J Control Release. 2013;171(3):269-279.
44. Gustafson JA, Ghandehari H. Silk-elastinlike protein polymers for matrix-mediated cancer gene therapy. Adv Drug Deliv Rev. 2010;62(15): 1509-1523.
45. Kar UK, Srivastava MK, Andersson A, et al. Novel CCL21-vault nanocapsule intratumoral delivery inhibits lung cancer growth. PloS One. 2011;6(5):e18758.
46. Han M, Kickhoefer VA, Nemerow GR, Rome LH. Targeted vault nanoparticles engineered with an endosomolytic peptide deliver biomolecules to the cytoplasm. ACS Nano. 2011;5(8):6128-6137.
47. Yildiz I, Shukla S, Steinmetz NF. Applications of viral nanoparticles in medicine. Curr Opin Biotechnol. 2011;22(6):901-908.
48. Wu Z, Chen K, Yildiz I, et al. Development of viral nanoparticles for efficient intracellular delivery. Nanoscale. 2012;4(11):3567-3576.
49. Pokorski JK, Steinmetz NF. The art of engineering viral nanoparticles. Mol Pharm. 2011;8(1):29-43.
50. Kedersha NL, Rome LH. Isolation and characterization of a novel ribonucleoprotein particle: large structures contain a single species of small RNA. J Cell Biol. 1986;103(3):699-709.
51. Suprenant KA. Vault ribonucleoprotein particles: sarcophagi, gondolas, or safety deposit boxes? Biochemistry. 2002;41(49):14447-14454.
52. Rome LH, Kickhoefer VA. Development of the vault particle as a platform technology. ACS Nano. 2013;7(2):889-902.
53. Berger W, Steiner E, Grusch M, Elbling L, Micksche M. Vaults and the major vault protein: novel roles in signal pathway regulation and immunity. Cell Mol Life Sci. 2009;66(1):43-61.
54. Goldsmith LE, Yu M, Rome LH, Monbouquette HG. Vault nanocapsule dissociation into halves triggered at low pH. Biochemistry. 2007;46(10):2865-2875.
55. Galaway FA, Stockley PG. MS2 viruslike particles: a robust, semisynthetic targeted drug delivery platform. Mol Pharm. 2013;10(1): 59-68.
56. Choi KM, Choi SH, Jeon H, Kim IS, Ahn HJ. Chimeric capsid protein as a nanocarrier for siRNA delivery: stability and cellular uptake of encapsulated siRNA. ACS Nano. 2011;5(11):8690-8699.
57. Mackay JA, Chilkoti A. Temperature sensitive peptides: engineering hyperthermia-directed therapeutics. Int J Hyperthermia. 2008;24(6): 483-495.
58. Urry DW, Parker TM, Reid MC, Gowda DC. Biocompatibility of the bioelastic materials, poly(gvgvp) and its gamma-irradiation cross-linked matrix-summary of generic biological test-results. J Bioactive Compat Polymers. 1991;6:263-282.
59. Domb AJ, Kost J, Wiseman DM. Handbook of Biodegradable Polymers. Amsterdam: Harwood; 1997.